Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Fezakinumab> ?p ?o }
Showing triples 1 to 62 of
62
with 100 triples per page.
- Fezakinumab abstract "Fezakinumab is a human monoclonal antibody against interleukin-22, designed for the treatment of psoriasis and rheumatoid arthritis.Wyeth discovered and initially developed the drug, and clinical development continued after that company was acquired by Pfizer. Fezakinumab, in combination with methotrexate, completed a phase II trial in rheumatoid arthritis, but data was not released. Development was discontinued in August 2011.".
- Fezakinumab atcPrefix "none".
- Fezakinumab casNumber "1007106-86-6".
- Fezakinumab fdaUniiCode "0S77U25XZ3".
- Fezakinumab wikiPageID "33024211".
- Fezakinumab wikiPageLength "2409".
- Fezakinumab wikiPageOutDegree "8".
- Fezakinumab wikiPageRevisionID "514521053".
- Fezakinumab wikiPageWikiLink Category:Wyeth.
- Fezakinumab wikiPageWikiLink Interleukin-22.
- Fezakinumab wikiPageWikiLink Interleukin_13.
- Fezakinumab wikiPageWikiLink Interleukin_22.
- Fezakinumab wikiPageWikiLink Methotrexate.
- Fezakinumab wikiPageWikiLink Pfizer.
- Fezakinumab wikiPageWikiLink Psoriasis.
- Fezakinumab wikiPageWikiLink Rheumatoid_arthritis.
- Fezakinumab wikiPageWikiLink Wyeth.
- Fezakinumab wikiPageWikiLinkText "Fezakinumab".
- Fezakinumab wikiPageWikiLinkText "fezakinumab".
- Fezakinumab atcPrefix "none".
- Fezakinumab c "6408".
- Fezakinumab casNumber "1007106".
- Fezakinumab chemspiderid "NA".
- Fezakinumab h "9873".
- Fezakinumab hasPhotoCollection Fezakinumab.
- Fezakinumab mabType "mab".
- Fezakinumab molecularWeight "143.87".
- Fezakinumab n "1706".
- Fezakinumab o "2016".
- Fezakinumab s "44".
- Fezakinumab source "u".
- Fezakinumab target Interleukin_13.
- Fezakinumab type "mab".
- Fezakinumab unii "0".
- Fezakinumab verifiedfields "changed".
- Fezakinumab verifiedrevid "457119778".
- Fezakinumab wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Fezakinumab wikiPageUsesTemplate Template:Drugbox.
- Fezakinumab wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Fezakinumab wikiPageUsesTemplate Template:Monoclonals_for_immune_system.
- Fezakinumab subject Category:Wyeth.
- Fezakinumab hypernym Antibody.
- Fezakinumab type Article.
- Fezakinumab type ChemicalSubstance.
- Fezakinumab type Company.
- Fezakinumab type Drug.
- Fezakinumab type Antibody.
- Fezakinumab type Article.
- Fezakinumab type Chemical.
- Fezakinumab type Company.
- Fezakinumab type Drug.
- Fezakinumab type ChemicalObject.
- Fezakinumab type Thing.
- Fezakinumab type Q8386.
- Fezakinumab comment "Fezakinumab is a human monoclonal antibody against interleukin-22, designed for the treatment of psoriasis and rheumatoid arthritis.Wyeth discovered and initially developed the drug, and clinical development continued after that company was acquired by Pfizer. Fezakinumab, in combination with methotrexate, completed a phase II trial in rheumatoid arthritis, but data was not released. Development was discontinued in August 2011.".
- Fezakinumab label "Fezakinumab".
- Fezakinumab sameAs فيزاكينوماب.
- Fezakinumab sameAs m.0h53gkx.
- Fezakinumab sameAs Q5446179.
- Fezakinumab sameAs Q5446179.
- Fezakinumab wasDerivedFrom Fezakinumab?oldid=514521053.
- Fezakinumab isPrimaryTopicOf Fezakinumab.